PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction

Obesity

Volumn 17, Issue 10, 2009, Pages 1924-1931

  Matsuo, Tomoaki ^a   Nakata, Yoshio ^a   Katayama, Yasutomi ^a   Iemitsu, Motoyuki ^b   Maeda, Seiji ^a   Okura, Tomohiro ^a   Kim, Maeng Kyu ^a   Ohkubo, Hiroyuki ^a   Hotta, Kikuko ^c   Tanaka, Kiyoji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b International Pacific University   (Japan)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CALORIC RESTRICTION; CHEMISTRY; FEMALE; GENETIC VARIABILITY; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MIDDLE AGED; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; CALORIC RESTRICTION; CHOLESTEROL; DNA; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; REGRESSION ANALYSIS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 70349504205     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.199     Document Type: Article

References (41)

1. Rexrode KM, Hennekens CH, Willett WC et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997;277:1539-1545.
2. Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-313.
3. World Health Organization. Obesity: preventing and managing the global epidemic. Report of the WHO Consultation of Obesity. Geneva, Switzerland, 1997.
4. Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int J Obes Relat Metab Disord 1998;22:684-687.
5. Kuzuya T. Prevalence of diabetes mellitus in Japan compiled from literature. Diabetes Res Clin Pract 1994;24(Suppl):S15-S21
6. JASSO. Guidelines for diagnosis and treatment in obesity and its comorbidities. The 20th Meeting, Tokyo, Japan, 1999.
7. Okura T, Tanaka K, Nakanishi T et al. Effects of obesity phenotype on coronary heart disease risk factors in response to weight loss. Obes Res 2002;10:757-766.
8. Tanaka K, Okura T, Shigematsu R et al. Target value of intraabdominal fat area for improving coronary heart disease risk factors. Obes Res 2004;12:695-703.
9. Eilat-Adar S, Eldar M, Goldbourt U. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol 2005;161: 352-358.
10. Moreno-Aliaga MJ, Santos JL, Marti A, Martínez JA. Does weight loss prognosis depend on genetic make-up? Obes Rev 2005;6:155-168.
11. Adamo KB, Tesson F. Genotype-specific weight loss treatment advice: how close are we? Appl Physiol Nutr Metab 2007;32:351-366.
12. Bouchard C, Pérusse L. Current status of the human obesity gene map. Obes Res 1996;4:81-90.
13. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006;14:529-644.
14. Vogels N, Mariman EC, Bouwman FG et al. Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor gamma2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms. Am J Clin Nutr 2005;82:740-746.
15. Vidal-Puig A, Jimenez-Liñan M, Lowell BB et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 1996;97:2553-2561.
16. Vidal-Puig AJ, Considine R V, Jimenez-Liñan M et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997;99:2416-2422.
17. Tanaka K, Nakadomo F, Watanabe K et al. Body composition prediction equations based on bioelectrical impedance and anthropometric variables for Japanese obese women. Am J Hum Biol 1992;4:739-745.
18. Yoshizumi T, Nakamura T, Yamane M et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999;211:283-286.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
20. Hirakawa M, Tanaka T, Hashimoto Y et al. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 2002;30:158-162.
21. Ohnishi Y, Tanaka T, Ozaki K et al. A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 2001;46:471-477.
22. Science and Technology Agency. Standard Tables of Food Composition in Japan, 4th revised edn. Printing Bureau, Ministry of Finance: Tokyo, 1982 (in Japanese).
23. Kumahara H, Schutz Y, Ayabe M et al. The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry. Br J Nutr 2004; 91:235-243.
24. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311-322.
25. Bouchard C, Tremblay A, Després JP et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990;322:1477-1482.
26. Hainer V, Stunkard AJ, Kunesová M et al. Intrapair resemblance in very low calorie diet-induced weight loss in female obese identical twins. Int J Obes Relat Metab Disord 2000;24:1051-1057.
27. Bouchard L, Tremblay A, Bouchard C, Pérusse L. Contribution of several candidate gene polymorphisms in the determination of adiposity changes: results from the Québec Family Study. Int J Obes (Lond) 2007;31: 891-899.
28. Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest 2006;116:581-589.
29. Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol Behav 2006;88:227-233.
30. Gearing KL, Göttlicher M, Widmark E et al. Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene superfamily. J Nutr 1994;124(8 Suppl):1284S-1288S.
31. Hara K, Kubota N, Tobe K et al. The role of PPARgamma as a thrifty gene both in mice and humans. Br J Nutr 2000;84(Suppl 2):S235-S239.
32. Yen CJ, Beamer BA, Negri C et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997;241:270-274.
33. Deeb SS, Fajas L, Nemoto M et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998;20:284-287.
34. Cecil JE, Fischer B, Doney AS et al. The Pro12Ala and C-681G variants of the PPARG locus are associated with opposing growth phenotypes in young schoolchildren. Diabetologia 2005;48:1496-1502.
35. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80.
36. Lindi VI, Uusitupa MI, Lindström J et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002;51:2581-2586.
37. Franks PW, Jablonski KA, Delahanty L et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007;50:2451-2460.
38. Adamo KB, Dent R, Langefeld CD et al. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 2007;15:1068-1075.
39. Nicklas BJ, van Rossum E F, Berman DM et al. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001;50:2172-2176.
40. Freathy RM, Timpson NJ, Lawlor DA et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 2008;57:1419-1426.
41. Goyenechea E, Dolores Parra M, Alfredo Martínez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br J Nutr 2006;96:965-972.